Letter to the Editor in Response to Zhou et al
J Infect Dis
.
2021 Oct 28;224(8):1442-1443.
doi: 10.1093/infdis/jiab362.
Authors
Sean Troth
1
,
Joan Butterton
1
,
Carisa Stadlman DeAnda
1
,
Patricia Escobar
1
,
Jay Grobler
1
,
Daria Hazuda
1
,
George Painter
2
3
4
Affiliations
1
Merck & Co, Kenilworth, New Jersey, USA.
2
Emory Institute of Drug Development, Emory University, Atlanta, Georgia, USA.
3
Drug Innovation Ventures at Emory, Atlanta, Georgia, USA.
4
Department of Pharmacology and Chemical Biology, Emory University, Atlanta, Georgia, USA.
PMID:
34251432
PMCID:
PMC8344688
DOI:
10.1093/infdis/jiab362
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Letter
Comment